论文部分内容阅读
目的对吡拉西坦与甘露醇在颅内肿瘤术后高颅内压临床治疗效果进行观察研究。方法选取2011年8月-2013年8月收治的60例颅内肿瘤术后高颅内压治疗的患者,随机平分为观察组和对照组各30例,观察组患者使用吡拉西坦进行药物治疗,对照组患者使用甘露醇进行药物治疗,比较2组患者的治疗效果和降低颅内压特点,并进行统计学分析研究。结果观察组总有效率为90.00%明显高于对照组的86.67%,差异无统计学意义(P>0.05);2种药物降低颅内压特点比较,差异无统计学意义(P>0.05)。结论吡拉西坦可有效降低颅内肿瘤术后高颅内压,可替代常规甘露醇用药,同时吡拉西坦具有护脑和促醒作用,对于术后患者的预后具有重要意义,具有推广引用价值。
Objective To observe the clinical effect of piracetam and mannitol after intracranial tumor intracranial hypertension. Methods Sixty patients with intracranial intracranial tumor treated with intracranial pressure after operation from August 2011 to August 2013 were randomly divided into observation group (30 cases) and control group (30 cases). Patients in the observation group were treated with piracetam The patients in the control group were treated with mannitol. The treatment effect and the intracranial pressure were compared between the two groups, and the statistical analysis was conducted. Results The total effective rate in observation group was 90.00%, which was significantly higher than that in control group (86.67%, P <0.05). There was no significant difference between the two drugs in reducing intracranial pressure (P> 0.05). Conclusion Piracetam can effectively reduce intracranial tumor intracranial pressure after high pressure, and can replace conventional mannitol, while piracetam has brain protection and arousal, for the prognosis of postoperative patients with great significance, with promotion Reference value.